The Analysis of Gene Variants Related to POCD in Elderly Patients

Status Not yet recruiting

Clinical Trial Summary

The pathophysiology of postoperative cognitive dysfunction (POCD) following surgery may be related to Alzheimer's disease. Different studies show that; low levels of glial cell line-derived growth factor are found in both POCD and Alzheimer, and brain cholinergic markers like Choline acetyl transferase activity, High affinity choline uptake activity, and Acetil Choline (Ach) activity are decreased in Alzheimer disease.We know cholinergic inputs in the basal forebrain have a critical role in many other functions including memory, attention, arousal and sensory processing. Cholinergic neuron located basal section of forebrain degenerate extensively in Alzheimer disease which shares similarities with postoperative delirium and POCD. Ach binds to two well-known receptors in brain that are Nicotinic receptors which implicate several important functions such as "memory, learning, arousal and reward" and Muscarinic receptors which are widely distributed in forebrain and play an important role of development delirium and POCD. Dysfunction of cholinergic system may be one key aspect of postoperative DELIRIUM, POCD and ALZHEIMER disease. In this investigation; we would like to evaluate the relationship between genes encoding inflammation-related mediators detected in postoperative cognitive dysfunction and gene variants in Alzheimer's disease in a larger panel for elder patients undergoing major urologic surgery. Therefore our study will focus on demographic information of the patients (age, gender, comorbidity), neurocognitive tests (1 week before the surgery, postoperative 1st week and postoperative 3rd month), intraoperative data (mean arterial pressure, heart rate, need for inotrope, duration of mechanical ventilation, need for transfusion), and biochemical tests (Preoperative and postoperative blood samples for each patient) which are APOE, phosphatidylinositol-binding clathrin assembly protein, CR1 - complement receptor 1, ATP-binding cassette transporter, IL6, TREM.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Cognitive Dysfunction

Clinical Trial Details

NCT number	NCT05419596
Study type	Observational
Source	Istanbul University
Contact	Meltem Savran Karadeniz, Assoc. Prof.
Phone	00904142000
Email	savran@istanbul.edu.tr
Status	Not yet recruiting
Phase
Start date	July 1, 2022
Completion date	July 25, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05273125` - MOBility Disorders Assessment in Patients With Mild COGnitive Disorders
Active, not recruiting	`NCT04049695` - Improving Cognition After Cancer	N/A
Completed	`NCT05912374` - Adapting a Behavioral Intervention to Accommodate Cognitive Dysfunction in People Who Inject Drugs	N/A
Recruiting	`NCT03977350` - Association Between qEEG Measure and Post-Operative Cognitive Dysfunction (POCD) and Postoperative Delirium (POD)
Not yet recruiting	`NCT06027632` - Remotely Supervised Computerized Cognitive Stimulation to Reduce Post-chemotherapy Cognitive Difficulties in Patients Treated for Localized Breast Cancer	N/A
Completed	`NCT00719628` - Depth of Anaesthesia and Cognitive Dysfunction	N/A
Terminated	`NCT00754013` - Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 6 To 10	Phase 3
Terminated	`NCT00754052` - Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17	Phase 3
Recruiting	`NCT05014399` - Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy
Completed	`NCT04966455` - Effect of Raisins on Cognitive Function in Healthy Older Adults	Phase 3
Recruiting	`NCT05372159` - Vanderbilt Memory and Aging Project
Completed	`NCT03243279` - BRS and Outcomes in Cardiothoracic Surgery
Completed	`NCT04093882` - The Relevance of the Blood-brain Barrier to Cognitive Dysfunction and Alzheimer's Disease
Recruiting	`NCT05732285` - A Pilot Randomized Controlled Trial: CoINTEGRATE	N/A
Completed	`NCT06059768` - Urdu Translation and Psychometric Analysis of Lawton IADLS.
Completed	`NCT04624529` - Validity and Reliability of a Self-evaluation Tool for Cognitive Deficits in the Acute Stage After Stroke
Completed	`NCT04562662` - Evaluation of mediVR-KAGURA Guided Therapy	N/A
Not yet recruiting	`NCT04079075` - Multiple Interventions to Prevent Cognitive Decline	N/A
Active, not recruiting	`NCT04638101` - Building the Path to Resilience in Preterm Infants: Mindfulness-based Intervention	N/A
Active, not recruiting	`NCT04556305` - Lifestyle Physical Activity and Cognitive Training Interventions	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.